To our knowledge, this is the first study reporting attenuated FGS together with reduced renal Il-1β and Il-13 mRNA expression after chronic treatment with the DPP4 inhibitor VIL in ZDF rats. The gene discussed is DPP4; the disease is focal segmental glomerulosclerosis.